Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis



Status:Completed
Conditions:Neurology, Multiple Sclerosis
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - 70
Updated:4/21/2016
Start Date:May 2011
End Date:February 2013

Use our guide to learn which trials are right for you!

A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

To evaluate the efficacy of three doses of XP19986 (arbaclofen placarbil) compared to
placebo for the treatment of spasticity in subjects with multiple sclerosis (MS).


Inclusion Criteria:

1. Has multiple sclerosis (MS) based on Poser or McDonald Criteria (all subtypes of MS
will be accepted, including relapsing remitting, primary or secondary progressive, if
disease is stable per exclusion criteria).

2. Maximum Ashworth Score Scale score of ≥ 2 in at least one of the following muscle
groups on either side of the body: hip abductors/adductors, knee flexors/extensors,
ankle flexors/extensors.

3. Expanded Disability Status Scale (EDSS) rating between 3.0-8.0 inclusive.

4. If a subject is on disease modifying MS treatment, the dosage, frequency, and route
of administration must be stable for at least 30 days before screening and is
expected to be stable throughout the study.

5. Spasticity Disability Rating of 2 or higher at Baseline.

6. Willing to discontinue and refrain from using for the duration of the study drugs for
the treatment of spasticity or likely to affect spasticity (including, but not
limited to, baclofen, tizanidine, diazepam, clonazepam, metaxalone, dantrolene,
cyclobenzaprine, carisoprodol, clonidine, vigabatrin, valproic acid and cannabis).

Exclusion Criteria:

1. Spasticity due to neurological disorder other than MS or other conditions that may
confound the assessment of spasticity.

2. Subject has clinically evident muscle contractures resulting in irreversible
spasticity in lower extremities.

3. Subjects who have suffered an acute relapse of MS (as determined by the Investigator)
within 90 days prior to Screening, or have had more than 1 relapse within the year
prior to Screening

4. Botulinum toxin injection within 6 months of Screening or has current residual
associated side effects at Screening.

5. Subjects receiving concomitant medication from more than one of the following three
drug classes: (Antiepileptic drugs, Tricyclic anti-depressants and Opioids)

6. Subjects on the following medications, at doses above the specified limits, are
excluded if they cannot maintain a level within these limits

- Gabapentin ≤ 1800 mg per day or pregabalin ≤ 150 mg per day

- Amitriptyline ≤ 75 mg per day or nortriptyline ≤ 75 mg per day

- Opioids ≤ 30 mg morphine equivalents per day.

7. Evidence of unstable or severe systemic illness, including but not limited to:
Cardiovascular disease (e.g., chronic ventricular arrhythmia, unstable angina or
CHF), respiratory disease (e.g., sleep apnea, COPD requiring oxygen therapy or
hospitalization in last year), endocrine disease, hepatic disease (e.g., chronic
active hepatitis), renal disease, or immunodeficiency.
We found this trial at
28
sites
Bingham Farms, Michigan 48025
?
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
?
mi
from
Akron, OH
Click here to add this to my saved trials
Albany, New York
?
mi
from
Albany, NY
Click here to add this to my saved trials
Albuquerque, New Mexico
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Asheville, North Carolina
?
mi
from
Asheville, NC
Click here to add this to my saved trials
Berkeley, California
?
mi
from
Berkeley, CA
Click here to add this to my saved trials
Denver, Colorado
?
mi
from
Denver, CO
Click here to add this to my saved trials
Detroit, Michigan
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Franklin, Tennessee
?
mi
from
Franklin, TN
Click here to add this to my saved trials
Indianapolis, Indiana
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Lake Barrington, Illinois
?
mi
from
Lake Barrington, IL
Click here to add this to my saved trials
Lenexa, Kansas
?
mi
from
Lenexa, KS
Click here to add this to my saved trials
Lexington, Kentucky
?
mi
from
Lexington, KY
Click here to add this to my saved trials
Nashville, Tennessee
?
mi
from
Nashville, TN
Click here to add this to my saved trials
Patchogue, New York
?
mi
from
Patchogue, NY
Click here to add this to my saved trials
Phoenix, Arizona 85013
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Plainview, New York
?
mi
from
Plainview, NY
Click here to add this to my saved trials
Port Charlotte, Florida
?
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
San Antonio, Texas
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Diego, California
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Sarasota, Florida
?
mi
from
Sarasota, FL
Click here to add this to my saved trials
Seattle, Washington
?
mi
from
Seattle, WA
Click here to add this to my saved trials
St. Petersburg, Florida
?
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Tacoma, Washington
?
mi
from
Tacoma, WA
Click here to add this to my saved trials
Tampa, Florida
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Toms River, New Jersey
?
mi
from
Toms River, NJ
Click here to add this to my saved trials
Tucson, Arizona
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Vienna, Virginia
?
mi
from
Vienna, VA
Click here to add this to my saved trials